Open access
Aug 2026
Potent Cross-Serotype Dengue Neutralization with Low ADE by AG-Strand-Targeting Anti-EDIII Antibodies
It is demonstrated that the AG-strand epitope can elicit broadly protective antibodies with reduced ADE risk, highlighting its potential as a strategic epitope for pan-DENV vaccine development.
Napon Nilchan, Anunyaporn Phungsom, Mongkhonphan Tantiwatcharakunthon et al.
· ACS Omega · 0 citations